文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

CPT1A过表达通过增强ACSL4琥珀酰化抑制铁死亡从而减轻脓毒症诱导的急性肺损伤:来自临床样本、小鼠模型和肺泡上皮细胞的证据

CPT1A overexpression alleviates sepsis-induced acute lung injury by inhibiting ferroptosis through the enhancement of ACSL4 succinylation: evidence from clinical samples, mouse models, and alveolar epithelial cells.
PubMed 文献 · Shock · 2025-10-21
一句话结论在脓毒症相关急性肺损伤中CPT1A表达下调,过表达CPT1A可通过增强ACSL4琥珀酰化、降低ACSL4表达抑制铁死亡并减轻肺损伤。

该研究在脓毒症诱导的急性肺损伤(SI-ALI)患者外周静脉血、盲肠结扎穿刺(CLP)C57BL/6小鼠模型及脂多糖(LPS)处理的MLE-12肺泡上皮细胞中检测CPT1A表达。结果显示CPT1A在SI-ALI中下调;体外过表达CPT1A通过增强ACSL4琥珀酰化降低ACSL4表达,从而抑制铁死亡,而过表达ACSL4可抵消CPT1A对铁死亡的抑制作用。小鼠中CPT1A过表达改善肺部病理并抑制肺内铁死亡激活。作者认为CPT1A通过促进ACSL4琥珀酰化抑制铁死亡来减轻SI-ALI,为SI-ALI治疗提供了新理论依据和潜在治疗靶点。

要点

  • 在脓毒症诱导的急性肺损伤患者外周静脉血、CLP小鼠模型及LPS处理的MLE-12细胞中,CPT1A表达均下调。
  • 体外过表达CPT1A可增强ACSL4琥珀酰化、降低ACSL4表达,从而抑制铁死亡。
  • 体外过表达ACSL4可抵消CPT1A介导的铁死亡抑制。
  • 小鼠中CPT1A过表达改善肺部病理并抑制肺内铁死亡激活。
  • 作者认为CPT1A通过促进ACSL4琥珀酰化抑制铁死亡来减轻SI-ALI,是潜在治疗靶点。

适用人群与场景

  • 脓毒症诱导的急性肺损伤(SI-ALI)患者的外周静脉血样本;盲肠结扎穿刺(CLP)的C57BL/6小鼠;脂多糖(LPS)处理的MLE-12肺泡上皮细胞。

研究设计与关键结果

  • 研究类型为结合临床样本、小鼠模型与肺泡上皮细胞的实验研究;检测SI-ALI患者外周静脉血、CLP小鼠及LPS处理MLE-12细胞中CPT1A水平。
  • CPT1A在SI-ALI中表达下调。
  • 体外过表达CPT1A通过增强ACSL4琥珀酰化、降低ACSL4表达抑制铁死亡;过表达ACSL4可抵消CPT1A介导的铁死亡抑制。
  • 小鼠中CPT1A过表达改善肺部病理并抑制肺内铁死亡激活。
  • 铁死亡通过丙二醛、谷胱甘肽、Fe2+水平及活性氧荧光强度评估。

证据类型、等级与局限

  • 证据类型:结合临床样本、小鼠模型和细胞实验的基础研究。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Sepsis-induced acute lung injury (SI-ALI) is strongly influenced by ferroptosis, a regulated cell death pathway. Carnitine palmitoyltransferase 1A (CPT1A), known for its lysine succinyltransferase activity, regulates succinylation but its function in ferroptosis and SI-ALI remains to be elucidated. This study aim to determine the influence of CPT1A on ferroptotic processes in SI-ALI and to reveal the key regulatory mechanisms involved. The SI-ALI model was generated in C57BL/6 mice via cecal ligation and puncture (CLP), while alveolar epithelial cells MLE-12 were treated with lipopolysaccharides (LPS) to mimic SI-ALI in vitro. Quantitative PCR and Western blotting were employed to evaluate CPT1A levels in peripheral venous blood samples from SI-ALI patients, as well as in both the mouse and cellular models of SI-ALI. Ferroptosis was evaluated by measuring malondialdehyde, glutathione, Fe 2+ levels, and reactive oxygen species fluorescence intensity. To elucidate the underlying mechanisms, co-immunoprecipitation (co-IP) and standard IP techniques were utilized. Our findings indicated that CPT1A was downregulated in SI-ALI. Overexpression of CPT1A inhibited ferroptosis in the in vitro SI-ALI model by enhancing ACSL4 succinylation, thereby reducing ACSL4 expression. Notably, overexpression of ACSL4 counteracted CPT1A-mediated ferroptosis suppression in vitro. Moreover, CPT1A overexpression ameliorated pulmonary pathology and suppressed ferroptosis activation in the lungs of SI-ALI mice. Collectively, the results indicate that CPT1A alleviated SI-ALI through the inhibition of ferroptosis by promoting ACSL4 succinylation, providing a novel theoretical foundation and potential therapeutic target for SI-ALI treatment.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Wang L, Sun X. CPT1A overexpression alleviates sepsis-induced acute lung injury by inhibiting ferroptosis through the enhancement of ACSL4 succinylation: evidence from clinical samples, mouse models, and alveolar epithelial cells. Shock. 2025. PMID: 41166123. doi:10.1097/SHK.0000000000002743

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。